127 related articles for article (PubMed ID: 12499809)
1. [Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules].
Kwon YM; Lee SK; Kim JS; Ro JY; Yu ES
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):223-7. PubMed ID: 12499809
[No Abstract] [Full Text] [Related]
2. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
[TBL] [Abstract][Full Text] [Related]
3. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
Watanabe M; Akagi S; Hamamoto S
Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
[No Abstract] [Full Text] [Related]
5. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
7. Case report combined hepatocellular and cholangiocarcinoma with sarcomatous transformation.
Boonsakan P; Thangnapakorn O; Tapaneeyakorn J; Kositchaiwat S; Bunyaratvej S
J Med Assoc Thai; 2007 Mar; 90(3):574-80. PubMed ID: 17427538
[TBL] [Abstract][Full Text] [Related]
8. Synchronous liver cancers: A rare tumor combination in an elderly Japanese woman.
Shigaki DM; Nekoba AC; Ide JY; Hardman JM; Tokeshi J
Hawaii Med J; 2006 Jun; 65(6):166-7, 178. PubMed ID: 16895268
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular carcinoma arising in hepatocellular adenoma].
Choe MS; Yu ES
Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):107-9. PubMed ID: 12499824
[No Abstract] [Full Text] [Related]
10. [Combined hepato-cholangiocarcinoma. Case presentation and literature review].
Salas AA; González AL; Goepfert RH
Rev Gastroenterol Mex; 2006; 71(4):483-6. PubMed ID: 17542282
[TBL] [Abstract][Full Text] [Related]
11. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.
Lin G; Toh CH; Wu RC; Ko SF; Ng SH; Chou WC; Tseng JH
Int J Clin Pract; 2008 Aug; 62(8):1199-205. PubMed ID: 17537192
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas.
Ariizumi S; Takasaki K; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S
Hepatogastroenterology; 2004; 51(56):500-4. PubMed ID: 15086191
[TBL] [Abstract][Full Text] [Related]
14. [Combined hepatocellular-cholangiocarcinoma].
Han JK; Kim SH; Kim SJ
Korean J Hepatol; 2007 Mar; 13(1):112-5. PubMed ID: 17380083
[No Abstract] [Full Text] [Related]
15. Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma.
Maeda T; Tsuneyoshi M; Takenaka K; Sugimachi K
Cancer; 1997 Aug; 80(3):514-6. PubMed ID: 9241086
[No Abstract] [Full Text] [Related]
16. Comparing combined hepatocellular-cholangiocarcinoma and cholangiocarcinoma: a clinicopathological study.
Lee CC; Wu CY; Chen JT; Chen GH
Hepatogastroenterology; 2002; 49(48):1487-90. PubMed ID: 12397714
[TBL] [Abstract][Full Text] [Related]
17. Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization.
Homayounfar K; Gunawan B; Cameron S; Haller F; Baumhoer D; Uecker S; Sander B; Ramadori G; Lorf T; Füzesi L
Hum Pathol; 2009 Jun; 40(6):834-42. PubMed ID: 19200581
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
[TBL] [Abstract][Full Text] [Related]
19. [A case of combined or mixed hepatocellular and cholangiocarcinoma with sarcomatous components--immunohistochemical characteristics and histogenesis].
Nakasho K; Yamanaka N; Okamoto E
Nihon Shokakibyo Gakkai Zasshi; 1996 Mar; 93(3):206-11. PubMed ID: 8721118
[No Abstract] [Full Text] [Related]
20. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
Hunt JP; Varnholt H
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
